Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
18.02
0.00 (0.00%)
At close: Apr 14, 2026, 4:00 PM EDT
18.01
-0.01 (-0.06%)
After-hours: Apr 14, 2026, 7:57 PM EDT
Assertio Holdings Employees
Assertio Holdings had 53 employees as of December 31, 2025. The number of employees decreased by 5 or -8.62% compared to the previous year.
Employees
53
Change (1Y)
-5
Growth (1Y)
-8.62%
Revenue / Employee
$2,239,868
Profits / Employee
-$573,113
Market Cap
116.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 53 | -5 | -8.62% |
| Dec 31, 2024 | 58 | 5 | 9.43% |
| Dec 31, 2023 | 53 | 23 | 76.67% |
| Dec 31, 2022 | 30 | 11 | 57.89% |
| Dec 31, 2021 | 19 | -8 | -29.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Lifecore Biomedical | 382 |
| Zhengye Biotechnology Holding | 277 |
| Anika Therapeutics | 235 |
| Alpha Teknova | 158 |
| Journey Medical | 58 |
| Cardiol Therapeutics | 18 |
ASRT News
- 6 days ago - Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio - Business Wire
- 6 days ago - Assertio Announces Agreement to be Acquired by Garda Therapeutics - Business Wire
- 13 days ago - Top 2 Health Care Stocks That May Implode In April - Benzinga
- 4 weeks ago - Assertio Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 6 weeks ago - Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - Business Wire
- 3 months ago - Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - Business Wire
- 3 months ago - Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - Business Wire
- 4 months ago - Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split - Business Wire